David Shaw’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

David Shaw’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,094	Closed	-$554K	–	5163
2022 Q4	$554K	Sell	45,094 -132,681	-75%	-$3.16M	﹤0.01%	3801
2022 Q3	$5.83M	Buy	177,775 +160,243	+914%	+$4.53M	0.01%	1915
2022 Q2	$330K	Sell	17,532 -17,424	-50%	-$334K	﹤0.01%	4312
2022 Q1	$613K	Buy	+34,956	New	+$717K	﹤0.01%	4242

David Shaw's CINC Position: Q1 2023 in Review

David Shaw sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 45,094 shares — an estimated $554K sold.

David Shaw first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $5.83M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

David Shaw reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
David Shaw sold 45,094 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $554K.
David Shaw first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
David Shaw's CinCor Pharma, Inc. Common Stock position peaked at $5.83M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.